查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1972633

脊椎穿刺针市场：按产品类型、规格、材质、应用和最终用户划分，全球预测，2026-2032年

Spinal Needle Market by Product Type, Gauge, Material, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，脊椎穿刺针市场价值将达到 3.5076 亿美元，到 2026 年将成长至 3.7198 亿美元，到 2032 年将达到 4.923 亿美元，年复合成长率为 4.96%。

主要市场统计数据
基准年 2025 3.5076亿美元
预计年份：2026年 3.7198亿美元
预测年份 2032 4.923亿美元
复合年增长率 (%) 4.96%

本报告全面概​​述了影响脊髓穿刺针策略的临床意义、产品发展、监管限制和相关人员。

脊髓穿刺针领域处于临床实践、製造技术和监管的交汇点，它塑造着现代医疗保健系统中麻醉、诊断和靶向鞘内治疗的实施方式。临床医生要求器械在组织触感、流动性和最大限度降低併发症风险之间取得平衡，而采购和供应部门则优先考虑一致性、可追溯性和与现有临床通讯协定的兼容性。随着时间的推移，材料的创新和针尖形状的改进改变了手术操作和医生的偏好，从而为不同的临床环境创造了差异化的产品价值提案。

识别临床、技术、监管和供应链技术的整合动态，以重塑脊椎穿刺针的开发和商业竞争。

近年来，一系列变革性的变化重新定义了脊髓穿刺针的设计、检验和临床应用方式。临床上，患者对舒适度和手术安全性的日益重视，促使人们更加关注超音波造影标记、非侵入性笔尖式穿刺针以及整合安全机制，以降低意外针刺伤和神经损伤的风险。除了这些临床因素外，人们也越来越重视训练工具，以便将手术的可重复性和设计优势转化为可衡量的疗效。

近期关税政策变化对脊椎穿刺针製造商原料采购、生产策略和供应连续性的累积影响分析

医疗器械零件和原材料关税政策的调整，导致製造商和医疗器械采购商的成本结构更加复杂。影响金属和聚合物进口的关税调整，进而影响脊椎穿刺针製造中常用的不銹钢、镀镍和特殊聚合物零件的成本结构。实际上，这些变化已经波及到采购决策，促使製造商重新评估供应商布局、重新谈判合同，并探索关键投入品的近岸外包方案，以降低跨境课税风险。

我们利用可操作的细分讯息，整合产品类型、临床应用、最终用户、量规选择和材料特性，来指导产品和商业决策。

精准理解产品和用途细分对于优化开发平臺和商业策略至关重要。产品类型差异化，包括涂层设计、传统针头、超音波造影针头和安全导向针头，旨在满足不同的临床和采购需求。传统针头设计进一步细分为笔尖型和昆克型，而安全装置则分为主动式和被动式系统，二者采用不同的机制来预防针刺伤和操作失误。这些材质和形状的选择直接影响治疗效果和临床医生的偏好，从而影响不同训练水平和治疗量环境下产品的推广应用。

区域策略观点：全球主要区域临床实务、管理体制与采购行为差异对医疗器材部署的影响

区域趋势影响着美洲、欧洲、中东和非洲以及亚太地区的临床实践模式、监管预期和采购行为，导致对脊椎穿刺针设计和供应链策略的需求存在差异。在美洲，医疗系统优先考虑手术效率、以报销主导的诊疗路径以及健全的医院采购计划，因此更倾向于选择那些手术可靠性高、临床医生认可度高且成本可预测的器械。北美和南美在监管核准和分销基础设施方面的差异也可能影响新器械的推出速度。

竞争格局分析揭示了产品创新、策略联盟、市场后研究和供应弹性如何推动供应商差异化和采购选择。

脊椎穿刺针领域的竞争动态由众多参与者共同塑造，其中包括成熟的医疗设备製造商、专业製造商以及专注于利基创新的参与企业。那些投资于渐进式设计改进（例如非侵入性针尖形状、先进涂层和超音波造影功能）的公司，往往会利用临床数据和培训项目来加速医疗专业人员的接受度。同时，那些将产品性能与完善的上市后监控和供应链透明度相结合的公司，能够降低采购风险，从而更容易获得医疗机构的认可。

为经营团队提供切实可行的优先建议，以加速临床部署、增强供应连续性并建立可持续的商业性差异化。

产业领导者应优先考虑均衡的产品组合策略，将创新投资与可证实的临床效益和运作可靠性相结合。对非侵入性探头形状、增强造影成像功能和检验的安全特性的投资，必须辅以严格的临床评估和有针对性的培训计划，以确保设计优势能够转化为医疗专业人员操作水平和患者疗效的显着提升。同时，领导者也必须投资于品管和可追溯性系统，以满足日益增长的监管要求和买家对医疗设备来源可追溯性的诉求。

采用透明且可重复的调查方法，整合直接的临床见解、监管和技术审查以及供应链映射，以检验结论。

本分析的研究方法结合了结构化的初步调查（受访者包括临床医生、供应链专家和采购经理）和对监管文件、技术文献及产品技术规范的系统性二次审查。初步调查旨在收集医疗专业人员对不同针头形状和规格选择在操作性、可视性和安全性方面的权衡意见。同时，采购相关人员也提供了关于供应商选择标准、库存管理方法以及与关税相关的采购决策的见解。这种基于三角验证的证据基础确保了技术知识与实际操作的一致性。

将临床重点、设计创新、监管合规性和供应链韧性联繫起来的全面整合，展现了实现永续产品成功的连贯路径。

总而言之，脊椎穿刺针市场格局正受到多种因素的影响而不断演变，例如临床对更安全、更可靠器械的需求、材料和设计的创新、贸易趋势的变化以及不同地区的预期差异。产品成功越来越依赖将可证实的临床效益与可靠的实证医学证据、品质系统和稳健的供应链结合。相关人员，将获得良好的成功实施记录和组织信任。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：脊髓穿刺针市场：依产品类型划分

  • 涂层类型
  • 传统的
    • 铅笔尖
    • 昆克角
  • 超音波造影
  • 安全
    • 主动安全装置
    • 被动式安全装置

第九章：脊髓穿刺针市场：依规格划分

  • 20G
  • 22G
  • 24G
  • 25G
  • 27G

第十章 脊椎穿刺针市场：依材质

  • 镀镍
  • 聚合物
  • 不銹钢
  • 特氟龙涂层

第十一章 脊髓穿刺针市场：依应用领域划分

  • 诊断性腰椎穿刺
  • 硬脊膜外麻醉
    • 脊髓硬膜外麻醉
    • 持续性脊髓镇痛
  • 鞘内注射
    • 化疗
    • 疼痛管理
  • 脊髓麻醉

第十二章：脊髓穿刺针市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院
    • 当地医院
    • 教学医院
  • 专业医疗中心

第十三章 脊椎穿刺针市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：脊髓穿刺针市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 脊髓穿刺针市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 美国：脊椎针市场

第十七章 中国：脊椎针市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Halyard Health, Inc.
  • ICU Medical, Inc.
  • Nipro Corporation
  • Pajunk GmbH Medizinprodukte
  • Smiths Medical, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
Product Code: MRR-9A6A6F2976B5

The Spinal Needle Market was valued at USD 350.76 million in 2025 and is projected to grow to USD 371.98 million in 2026, with a CAGR of 4.96%, reaching USD 492.30 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 350.76 million
Estimated Year [2026] USD 371.98 million
Forecast Year [2032] USD 492.30 million
CAGR (%) 4.96%

Comprehensive introduction framing clinical significance, product evolution, regulatory constraints, and stakeholder priorities shaping spinal needle strategy

The spinal needle sector sits at the intersection of clinical practice, manufacturing engineering, and regulatory oversight, shaping how anesthesia, diagnostics, and targeted intrathecal therapies are delivered in modern healthcare systems. Clinicians demand devices that balance tissue feel, fluid flow, and minimized complication risk, while procurement and supply functions prioritize consistency, traceability, and compatibility with existing clinical protocols. Over time, material innovations and refinements to point geometry have altered procedural ergonomics and practitioner preference, creating differentiated product value propositions across clinical settings.

As device developers respond to clinician feedback, iterative improvements in coatings, echogenic design, and safety features have emerged, influencing device selection and clinical training priorities. Regulatory pathways and post-market surveillance data increasingly inform purchasing decisions, requiring manufacturers to align product specifications with evidence demonstrating safety and ease of use. Concurrently, supply chain resilience and raw material sourcing exert practical influence on manufacturing cadence and quality control, underscoring the need for integrated strategic planning across design, production, and commercialization functions.

This introduction frames subsequent analysis by clarifying how clinical imperatives, product design choices, and system-level considerations converge to shape stakeholder priorities. It sets the context for understanding transformative shifts, trade policy impacts, segmentation nuances, regional dynamics, competitive behavior, and actionable steps leaders can adopt to sustain innovation and operational excellence.

Identification of converging clinical, technological, regulatory, and supply chain forces that are reshaping spinal needle development and commercial competition

Recent years have produced a cluster of transformative shifts that are redefining how spinal needles are conceived, validated, and adopted in clinical practice. On the clinical front, expanding expectations for patient comfort and procedural safety have accelerated interest in echogenic markings, atraumatic pencil point tips, and integrated safety mechanisms that reduce the risk of inadvertent needle-stick or nerve trauma. These clinical drivers are complemented by growing emphasis on procedural reproducibility and training tools that help practitioners translate design advantages into measurable outcomes.

Technological advances in material science and surface engineering are enabling new combinations of lubrication, corrosion resistance, and echogenicity, which in turn influence handling characteristics and visibility under ultrasound. Meanwhile, regulatory scrutiny has increased around device traceability, sterilization validation, and post-market follow-up, pressing manufacturers to invest in robust quality systems and clinical evidence generation. Supply chain digitization and traceability platforms are facilitating more transparent sourcing and inventory management across distribution channels.

Commercially, buyers are demanding product differentiation alongside service-level assurances such as validated supply continuity, clinician education programs, and documentation that supports hospital credentialing. These converging forces are shifting competitive dynamics from pure cost competition toward solution-based offers that bundle device performance with ecosystem support for adoption and safe use. The result is a landscape where innovation, compliance, and distribution reliability determine long-term commercial viability.

Analysis of the cumulative consequences of recent tariff policy shifts on materials sourcing, production strategies, and supply continuity for spinal needle manufacturers

Policy shifts in tariff schedules for medical components and raw materials have introduced a more complex cost landscape for manufacturers and healthcare purchasers. Tariff adjustments affecting metals and polymer imports impact the cost structure of stainless steel, nickel plating, and specialty polymer components commonly used in spinal needle production. In practice, these changes reverberate through procurement decisions, prompting manufacturers to reassess supplier footprints, renegotiate contracts, and explore nearshoring options for critical inputs to mitigate exposure to cross-border levies.

Beyond direct material cost impacts, tariff measures have secondary effects on lead times and inventory strategies. Companies with finely tuned just-in-time operations face heightened risk, incentivizing buffer inventory, multi-sourcing strategies, and contractual flexibility to maintain continuity of supply. For healthcare providers, these supply-side adjustments can affect purchasing timelines and the selection of product variants that best align with cost containment and clinical requirements. Importantly, tariffs can accelerate consolidation of production in jurisdictions with favorable trade terms or closer proximity to large end markets to preserve competitive pricing.

Regulatory compliance and device quality must remain uncompromised amid any adjustments to sourcing or production geography, so technical transfer, validation, and supply chain audits become critical activities. Companies that proactively map tariff exposures and integrate them into procurement and product strategies are better positioned to sustain product availability and deliver consistent clinical performance while navigating an evolving trade environment.

Actionable segmentation intelligence integrating product type, clinical applications, end users, gauge choices, and material attributes to guide product and commercial decisions

A nuanced understanding of product and usage segmentation is essential for tailoring development pipelines and commercial strategies. Within product type differentiation, coated designs, conventional needles, echogenic variants, and safety-focused models each address distinct clinical and procurement priorities; conventional designs further split into pencil point and Quincke point configurations, while safety devices subdivide into active and passive systems that incorporate different mechanisms to prevent needlestick or procedural error. These material and geometric choices translate directly into procedural performance and clinician preference, shaping adoption pathways in environments with varying training levels and procedural volumes.

Application segmentation highlights diagnostic lumbar puncture, epidural anesthesia, intrathecal injection, and spinal anesthesia as core use cases that set divergent device requirements; for example, epidural anesthesia encompasses combined spinal-epidural and continuous spinal analgesia techniques that demand different catheter compatibility and tactile feedback, and intrathecal injection spans chemotherapy and pain management protocols with differing sterility and dosing considerations. End user profiling differentiates ambulatory surgical centers, clinics, hospitals, and specialty centers, with hospitals further characterized as community or teaching institutions that have different formulary governance, procurement sophistication, and clinical specialization.

Technical specifications such as gauge and material offer additional axes for segmentation: gauge options including 20G, 22G, 24G, 25G, and 27G inform trade-offs between flow rate and tissue trauma, while materials like nickel-plated components, polymers, stainless steel, and Teflon coatings influence manufacturability, sterilization compatibility, and tactile properties. Integrating these segmentation dimensions yields a granular framework that supports targeted product positioning, regulatory planning, and commercial alignment with distinct clinical workflows and procurement behaviors.

Regional strategic perspectives highlighting how clinical practice, regulatory regimes, and procurement behavior differ across key global territories and influence device adoption

Regional dynamics shape clinical practice patterns, regulatory expectations, and procurement behaviors across the Americas, Europe Middle East & Africa, and Asia-Pacific, producing differentiated demand signals for spinal needle designs and supply chain strategies. In the Americas, healthcare systems emphasize procedural efficiency, reimbursement-driven care pathways, and robust hospital procurement programs, which often favor devices that demonstrate procedural reliability, clinician acceptability, and cost predictability. North and South American variation in regulatory approvals and distribution infrastructures can also influence rollout cadence for new device variants.

The Europe Middle East & Africa region presents a mosaic of regulatory regimes, varying clinical guidelines, and diverse hospital infrastructures. In many EMEA settings, stringent regulatory documentation and strong post-market surveillance requirements drive emphasis on traceability and long-term safety data, while cost-containment pressures encourage adoption of devices that strike a balance between innovation and proven performance. The Asia-Pacific region displays rapid demand growth driven by expanding surgical capacity, increased adoption of minimally invasive and image-guided techniques, and diversified supplier ecosystems; manufacturers often prioritize localized partnerships and production arrangements to address tariff sensitivities and distribution complexities.

Across all regions, differences in training paradigms, ultrasound adoption, procedural volumes, and procurement centralization influence which product attributes gain traction. Manufacturers and providers that tailor product introductions, evidence generation, and supply arrangements to regional nuances will more effectively align clinical and commercial outcomes with local expectations.

Competitive landscape analysis revealing how product innovation, strategic partnerships, post-market surveillance, and supply resilience drive supplier differentiation and procurement choices

Competitive dynamics in the spinal needle arena are shaped by a mix of established medical device firms, specialty manufacturers, and newer entrants focused on niche innovation. Firms that have invested in incremental design improvements, such as atraumatic tip geometries, advanced coatings, and echogenic features, tend to leverage clinical data and training programs to accelerate practitioner adoption. At the same time, companies that combine product performance with robust post-market surveillance and supply chain transparency achieve stronger institutional acceptance due to reduced perceived procurement risk.

Acquisition and partnership activity is common as larger firms seek to complement product portfolios with novel materials or safety mechanisms developed by smaller innovators. Strategic alliances with research institutions and clinical centers support evidence generation aimed at demonstrating procedural benefits in real-world settings. Moreover, manufacturers are increasingly differentiating through service-level offerings such as clinician education, inventory management tools, and documentation packages that aid credentialing and regulatory compliance in hospitals and specialty centers.

Supply chain resilience and manufacturing quality remain decisive factors in supplier selection. Organizations that can demonstrate validated production processes, redundancy in sourcing for critical inputs, and rapid technical transfer capabilities gain a competitive advantage when customers prioritize continuity of care and predictable device performance. Overall, company strategies that integrate product excellence with operational reliability and clinical support deliver the most compelling value proposition to healthcare purchasers and practitioners.

Practical and prioritized recommendations for executives to accelerate clinical adoption, strengthen supply continuity, and build durable commercial differentiation

Industry leaders should prioritize a balanced portfolio strategy that aligns innovation investments with demonstrable clinical benefits and operational reliability. Investing in atraumatic tip geometries, echogenic enhancements, and validated safety features should be accompanied by rigorous clinical evaluation and targeted training programs to ensure that design advantages translate into measurable improvements in practitioner performance and patient outcomes. Simultaneously, leaders must invest in quality management and traceability systems to meet heightened regulatory expectations and purchaser demands for documented device provenance.

Supply chain strategies must diversify sourcing for critical inputs and consider nearshoring or multi-sourcing to mitigate tariff and logistics risk. Companies should conduct supplier risk assessments, establish dual-source agreements where feasible, and maintain validated technical transfer pathways to preserve product quality during geographic shifts in manufacturing. Engaging early with procurement and clinical stakeholders in target regions will ensure that product introductions reflect local practice patterns, regulatory requirements, and inventory management norms.

Commercially, firms should package devices with adoption support services such as clinician training modules, adoption roadmaps, and inventory optimization tools to reduce friction during rollout. Pricing strategies should reflect total cost of ownership and clinical value rather than unit price alone, enabling procurement teams to make decisions that balance cost containment with procedural quality. Finally, continual investment in post-market data collection and real-world evidence will strengthen product positioning and support long-term relationships with hospital systems and specialty centers.

Transparent and reproducible research methodology integrating primary clinician insight, regulatory and technical review, and supply chain mapping to validate conclusions

The research approach underpinning this analysis combined structured primary engagement with clinicians, supply chain specialists, and procurement leaders, alongside systematic secondary review of regulatory filings, technical literature, and product technical specifications. Primary input focused on eliciting practitioner perspectives on handling, visualization, and safety trade-offs across different tip geometries and gauge selections, while procurement stakeholders provided insight on supplier qualification criteria, inventory practices, and tariff-related sourcing decisions. This triangulated evidence base ensured that technical observations aligned with operational realities.

Secondary investigations examined material properties, sterilization compatibility, and design features such as coating technologies and echogenic patterning to understand their practical implications for manufacturability and clinical handling. Regulatory dossiers and post-market notices were reviewed to capture compliance histories and safety signal patterns that influence institutional confidence. Supply chain mapping and supplier qualification information were analyzed to assess potential vulnerabilities and opportunities for strategic sourcing adjustments in response to tariff dynamics.

Throughout the process, findings were validated through cross-functional workshops that reconciled clinical needs with engineering constraints and procurement imperatives. The methodology prioritized transparency, reproducibility, and relevance to decision-makers by linking technical attributes to adoption barriers and supply chain considerations that directly affect product introduction and sustained use.

Concluding synthesis that ties clinical priorities, design innovation, regulatory compliance, and supply chain resilience into a coherent pathway for sustained product success

In summary, the spinal needle landscape is evolving under the influence of clinical demand for safer, more reliable devices, material and design innovations, shifting trade dynamics, and differentiated regional expectations. Product success increasingly depends on coupling demonstrable procedural advantages with robust evidence, quality systems, and resilient supply arrangements. Stakeholders that align design priorities with clinician needs, and that proactively address sourcing and regulatory complexity, will achieve superior adoption outcomes and institutional trust.

Operationally, organizations must pursue integrated strategies that encompass targeted product development, evidence generation, and supply chain diversification. Commercial success will favor suppliers who present a complete value proposition: consistent device performance, thorough documentation, clinician support, and contingency planning for cross-border disruptions. Regional tailoring of introductions and partnerships will accelerate acceptance in diverse regulatory and clinical environments.

Taken together, the insights presented herein provide a framework for decision-makers to prioritize investments, partnership models, and operational safeguards that support safe, efficient, and evidence-driven spinal needle utilization across clinical settings. Implementing these recommendations will strengthen both clinical outcomes and long-term commercial resilience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Spinal Needle Market, by Product Type

  • 8.1. Coated
  • 8.2. Conventional
    • 8.2.1. Pencil Point
    • 8.2.2. Quincke Point
  • 8.3. Echogenic
  • 8.4. Safety
    • 8.4.1. Active Safety
    • 8.4.2. Passive Safety

9. Spinal Needle Market, by Gauge

  • 9.1. 20G
  • 9.2. 22G
  • 9.3. 24G
  • 9.4. 25G
  • 9.5. 27G

10. Spinal Needle Market, by Material

  • 10.1. Nickel Plated
  • 10.2. Polymer
  • 10.3. Stainless Steel
  • 10.4. Teflon Coated

11. Spinal Needle Market, by Application

  • 11.1. Diagnostic Lumbar Puncture
  • 11.2. Epidural Anesthesia
    • 11.2.1. Combined Spinal Epidural
    • 11.2.2. Continuous Spinal Analgesia
  • 11.3. Intrathecal Injection
    • 11.3.1. Chemotherapy
    • 11.3.2. Pain Management
  • 11.4. Spinal Anesthesia

12. Spinal Needle Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals
    • 12.3.1. Community Hospitals
    • 12.3.2. Teaching Hospitals
  • 12.4. Specialty Centers

13. Spinal Needle Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Spinal Needle Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Spinal Needle Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Spinal Needle Market

17. China Spinal Needle Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. B. Braun Melsungen AG
  • 18.6. Baxter International Inc.
  • 18.7. Becton, Dickinson and Company
  • 18.8. Boston Scientific Corporation
  • 18.9. Cook Medical LLC
  • 18.10. Halyard Health, Inc.
  • 18.11. ICU Medical, Inc.
  • 18.12. Nipro Corporation
  • 18.13. Pajunk GmbH Medizinprodukte
  • 18.14. Smiths Medical, Inc.
  • 18.15. Teleflex Incorporated
  • 18.16. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL SPINAL NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SPINAL NEEDLE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SPINAL NEEDLE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SPINAL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SPINAL NEEDLE MARKET SIZE, BY GAUGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SPINAL NEEDLE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SPINAL NEEDLE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SPINAL NEEDLE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SPINAL NEEDLE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SPINAL NEEDLE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SPINAL NEEDLE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES SPINAL NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA SPINAL NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SPINAL NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SPINAL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SPINAL NEEDLE MARKET SIZE, BY COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SPINAL NEEDLE MARKET SIZE, BY COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SPINAL NEEDLE MARKET SIZE, BY COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SPINAL NEEDLE MARKET SIZE, BY PENCIL POINT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SPINAL NEEDLE MARKET SIZE, BY PENCIL POINT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SPINAL NEEDLE MARKET SIZE, BY PENCIL POINT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SPINAL NEEDLE MARKET SIZE, BY QUINCKE POINT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SPINAL NEEDLE MARKET SIZE, BY QUINCKE POINT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SPINAL NEEDLE MARKET SIZE, BY QUINCKE POINT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SPINAL NEEDLE MARKET SIZE, BY ECHOGENIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SPINAL NEEDLE MARKET SIZE, BY ECHOGENIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SPINAL NEEDLE MARKET SIZE, BY ECHOGENIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SPINAL NEEDLE MARKET SIZE, BY SAFETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SPINAL NEEDLE MARKET SIZE, BY SAFETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SPINAL NEEDLE MARKET SIZE, BY SAFETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SPINAL NEEDLE MARKET SIZE, BY SAFETY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SPINAL NEEDLE MARKET SIZE, BY ACTIVE SAFETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SPINAL NEEDLE MARKET SIZE, BY ACTIVE SAFETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SPINAL NEEDLE MARKET SIZE, BY ACTIVE SAFETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SPINAL NEEDLE MARKET SIZE, BY PASSIVE SAFETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SPINAL NEEDLE MARKET SIZE, BY PASSIVE SAFETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SPINAL NEEDLE MARKET SIZE, BY PASSIVE SAFETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SPINAL NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SPINAL NEEDLE MARKET SIZE, BY 20G, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SPINAL NEEDLE MARKET SIZE, BY 20G, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SPINAL NEEDLE MARKET SIZE, BY 20G, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SPINAL NEEDLE MARKET SIZE, BY 22G, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SPINAL NEEDLE MARKET SIZE, BY 22G, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SPINAL NEEDLE MARKET SIZE, BY 22G, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SPINAL NEEDLE MARKET SIZE, BY 24G, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SPINAL NEEDLE MARKET SIZE, BY 24G, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SPINAL NEEDLE MARKET SIZE, BY 24G, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SPINAL NEEDLE MARKET SIZE, BY 25G, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SPINAL NEEDLE MARKET SIZE, BY 25G, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SPINAL NEEDLE MARKET SIZE, BY 25G, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SPINAL NEEDLE MARKET SIZE, BY 27G, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SPINAL NEEDLE MARKET SIZE, BY 27G, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SPINAL NEEDLE MARKET SIZE, BY 27G, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SPINAL NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SPINAL NEEDLE MARKET SIZE, BY NICKEL PLATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SPINAL NEEDLE MARKET SIZE, BY NICKEL PLATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SPINAL NEEDLE MARKET SIZE, BY NICKEL PLATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SPINAL NEEDLE MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SPINAL NEEDLE MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SPINAL NEEDLE MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SPINAL NEEDLE MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SPINAL NEEDLE MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SPINAL NEEDLE MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SPINAL NEEDLE MARKET SIZE, BY TEFLON COATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SPINAL NEEDLE MARKET SIZE, BY TEFLON COATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SPINAL NEEDLE MARKET SIZE, BY TEFLON COATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SPINAL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SPINAL NEEDLE MARKET SIZE, BY DIAGNOSTIC LUMBAR PUNCTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SPINAL NEEDLE MARKET SIZE, BY DIAGNOSTIC LUMBAR PUNCTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SPINAL NEEDLE MARKET SIZE, BY DIAGNOSTIC LUMBAR PUNCTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SPINAL NEEDLE MARKET SIZE, BY COMBINED SPINAL EPIDURAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SPINAL NEEDLE MARKET SIZE, BY COMBINED SPINAL EPIDURAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SPINAL NEEDLE MARKET SIZE, BY COMBINED SPINAL EPIDURAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SPINAL NEEDLE MARKET SIZE, BY CONTINUOUS SPINAL ANALGESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SPINAL NEEDLE MARKET SIZE, BY CONTINUOUS SPINAL ANALGESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SPINAL NEEDLE MARKET SIZE, BY CONTINUOUS SPINAL ANALGESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SPINAL NEEDLE MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SPINAL NEEDLE MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SPINAL NEEDLE MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SPINAL NEEDLE MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SPINAL NEEDLE MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SPINAL NEEDLE MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SPINAL NEEDLE MARKET SIZE, BY SPINAL ANESTHESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL SPINAL NEEDLE MARKET SIZE, BY SPINAL ANESTHESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SPINAL NEEDLE MARKET SIZE, BY SPINAL ANESTHESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SPINAL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SPINAL NEEDLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SPINAL NEEDLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SPINAL NEEDLE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SPINAL NEEDLE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SPINAL NEEDLE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SPINAL NEEDLE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL SPINAL NEEDLE MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SPINAL NEEDLE MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SPINAL NEEDLE MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SPINAL NEEDLE MARKET SIZE, BY TEACHING HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL SPINAL NEEDLE MARKET SIZE, BY TEACHING HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL SPINAL NEEDLE MARKET SIZE, BY TEACHING HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SPINAL NEEDLE MARKET SIZE, BY SPECIALTY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SPINAL NEEDLE MARKET SIZE, BY SPECIALTY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SPINAL NEEDLE MARKET SIZE, BY SPECIALTY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL SPINAL NEEDLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS SPINAL NEEDLE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS SPINAL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS SPINAL NEEDLE MARKET SIZE, BY SAFETY, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS SPINAL NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS SPINAL NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS SPINAL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS SPINAL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA SPINAL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA SPINAL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA SPINAL NEEDLE MARKET SIZE, BY SAFETY, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA SPINAL NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA SPINAL NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA SPINAL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA SPINAL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA SPINAL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA SPINAL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA SPINAL NEEDLE MARKET SIZE, BY SAFETY, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA SPINAL NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA SPINAL NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA SPINAL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA SPINAL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA SPINAL NEEDLE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA SPINAL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA SPINAL NEEDLE MARKET SIZE, BY SAFETY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA SPINAL NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA SPINAL NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA SPINAL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA SPINAL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE SPINAL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE SPINAL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE SPINAL NEEDLE MARKET SIZE, BY SAFETY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE SPINAL NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE SPINAL NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE SPINAL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE SPINAL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST SPINAL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST SPINAL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST SPINAL NEEDLE MARKET SIZE, BY SAFETY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST SPINAL NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST SPINAL NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST SPINAL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST SPINAL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA SPINAL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA SPINAL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA SPINAL NEEDLE MARKET SIZE, BY SAFETY, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA SPINAL NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA SPINAL NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA SPINAL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA SPINAL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC SPINAL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC SPINAL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC SPINAL NEEDLE MARKET SIZE, BY SAFETY, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC SPINAL NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC SPINAL NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC SPINAL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC SPINAL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL SPINAL NEEDLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN SPINAL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN SPINAL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN SPINAL NEEDLE MARKET SIZE, BY SAFETY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN SPINAL NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN SPINAL NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN SPINAL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN SPINAL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 206. GCC SPINAL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. GCC SPINAL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. GCC SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
  • TABLE 209. GCC SPINAL NEEDLE MARKET SIZE, BY SAFETY, 2018-2032 (USD MILLION)
  • TABLE 210. GCC SPINAL NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 211. GCC SPINAL NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 212. GCC SPINAL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. GCC SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 214. GCC SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 215. GCC SPINAL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. GCC SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION SPINAL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION SPINAL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION SPINAL NEEDLE MARKET SIZE, BY SAFETY, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION SPINAL NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION SPINAL NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION SPINAL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION SPINAL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS SPINAL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS SPINAL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS SPINAL NEEDLE MARKET SIZE, BY SAFETY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS SPINAL NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS SPINAL NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS SPINAL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS SPINAL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 239. G7 SPINAL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. G7 SPINAL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. G7 SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
  • TABLE 242. G7 SPINAL NEEDLE MARKET SIZE, BY SAFETY, 2018-2032 (USD MILLION)
  • TABLE 243. G7 SPINAL NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 244. G7 SPINAL NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 245. G7 SPINAL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. G7 SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 247. G7 SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 248. G7 SPINAL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. G7 SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 250. NATO SPINAL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. NATO SPINAL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. NATO SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
  • TABLE 253. NATO SPINAL NEEDLE MARKET SIZE, BY SAFETY, 2018-2032 (USD MILLION)
  • TABLE 254. NATO SPINAL NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 255. NATO SPINAL NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 256. NATO SPINAL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. NATO SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 258. NATO SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 259. NATO SPINAL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. NATO SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 261. GLOBAL SPINAL NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES SPINAL NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES SPINAL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES SPINAL NEEDLE MARKET SIZE, BY SAFETY, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES SPINAL NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES SPINAL NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES SPINAL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES SPINAL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA SPINAL NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA SPINAL NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA SPINAL NEEDLE MARKET SIZE, BY CONVENTIONAL, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA SPINAL NEEDLE MARKET SIZE, BY SAFETY, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA SPINAL NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA SPINAL NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA SPINAL NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA SPINAL NEEDLE MARKET SIZE, BY EPIDURAL ANESTHESIA, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA SPINAL NEEDLE MARKET SIZE, BY INTRATHECAL INJECTION, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA SPINAL NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA SPINAL NEEDLE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)